Mar. 6 at 4:25 PM
@mikeg1999 I respect your opinion and you may be right about
$MXCT vs.
$VRTX and
$CRSP
My investment thesis is not predicated exclusively on Casgevy; although it does offer proof of concept, to a meaningful extent.
I like MaxCyte’s platform and I like their strong cash position, as well as what I view as the industry bottoming out in terms of capex across the CGT space as a whole.
Mxct is a penny stock now, unfortunately; but it didn't start out this way, and they have around 150M+ in the bank with no debt, which is nearly double their market cap.
Combine that with diminishing opex and an assortment of 32 SPL agreements which includes multiple shots on goal for some indications and you have an interesting pick and shovel play with the ability to leverage cash meaningfully - either via M&A activity, or scaling up if capex meaningfully improves in the mid term.
Just my thoughts. I know nothing.
Wishing us all great luck! 🩵
